Santhera Pharmaceuticals (Switzerland) Today
| SANN Stock | CHF 9.25 0.33 3.44% |
Performance0 of 100
| Odds Of DistressOver 65
|
Santhera Pharmaceuticals is selling for under 9.25 as of the 14th of December 2024; that is 3.44 percent decrease since the beginning of the trading day. The stock's lowest day price was 9.2. Santhera Pharmaceuticals has more than 65 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 14th of November 2024 and ending today, the 14th of December 2024. Click here to learn more.
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for orphan and other diseases with high unmet medical needs in the European countries. Santhera Pharmaceuticals Holding AG is headquartered in Pratteln, Switzerland. The company has 61.81 M outstanding shares. More on Santhera Pharmaceuticals Holding
Moving together with Santhera Stock
Moving against Santhera Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Santhera Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Santhera Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Santhera Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Santhera Pharmaceuticals Holding (SANN) is traded on SIX Swiss Exchange in Switzerland and employs 39 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 50.45 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Santhera Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Santhera Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Santhera Pharmaceuticals operates under Healthcare sector and is part of Biotechnology industry. The entity has 61.81 M outstanding shares.
Santhera Pharmaceuticals Holding has accumulated about 21.21 M in cash with (37.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.07.
Check Santhera Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationSanthera Pharmaceuticals shows a total of 61.81 Million outstanding shares. Santhera Pharmaceuticals has 18.77 % of its outstanding shares held by insiders and 3.5 % owned by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Santhera Ownership Details
Santhera Pharmaceuticals Risk Profiles
Although Santhera Pharmaceuticals' alpha and beta are two of the key measurements used to evaluate Santhera Pharmaceuticals' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.75 | |||
| Semi Deviation | 2.14 | |||
| Standard Deviation | 2.54 | |||
| Variance | 6.45 |
Santhera Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Santhera Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Watchlist Optimization Now
Watchlist OptimizationOptimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
| All Next | Launch Module |
Santhera Pharmaceuticals Corporate Management
Elected by the shareholders, the Santhera Pharmaceuticals' board of directors comprises two types of representatives: Santhera Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Santhera. The board's role is to monitor Santhera Pharmaceuticals' management team and ensure that shareholders' interests are well served. Santhera Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Santhera Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Eva Kalias | Head Communications | Profile | |
| FCMA CGMA | Chief Officer | Profile | |
| Shabir MD | Chief Officer | Profile | |
| Thomas Meier | Founder Chairman | Profile | |
| Dario Eklund | Chief Officer | Profile | |
| Neville MD | Head Management | Profile | |
| Gnther Metz | Head VP | Profile |
Additional Tools for Santhera Stock Analysis
When running Santhera Pharmaceuticals' price analysis, check to measure Santhera Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Santhera Pharmaceuticals is operating at the current time. Most of Santhera Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Santhera Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Santhera Pharmaceuticals' price. Additionally, you may evaluate how the addition of Santhera Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.